PHK
NVS icon

Point72 Hong Kong’s Novartis NVS Stock Holding History

Point72 Hong Kong’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7,392
Closed -$894K – 587
2025
Q2 		$894K Buy
7,392
+3,550
+92% +$400K 0.06% 212
2025
Q1 		$428K Buy
+3,842
New +$409K 0.03% 260
2024
Q1 		– Sell
-8,607
Closed -$869K – 728
2023
Q4 		$869K Buy
+8,607
New +$831K 0.05% 299

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Hong Kong's NVS Position: Q3 2025 in Review

Point72 Hong Kong sold out of Novartis (NVS) in Q3 2025, closing a stake of 7,392 shares — an estimated $894K sold.

Point72 Hong Kong first reported a position in NVS in Q4 2023 and held it in 3 quarters. The position peaked at $894K in Q2 2025. 1,401 funds tracked by Wall St. Rank hold NVS as of Q3 2025.

  • Point72 Hong Kong reported no remaining Novartis position as of Q3 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 7,392 Novartis shares in Q3 2025, an estimated $894K.
  • Point72 Hong Kong first reported a position in Novartis in Q4 2023 and held it in 3 quarters.
  • Point72 Hong Kong's Novartis position peaked at $894K in Q2 2025.
  • 1,401 funds tracked by Wall St. Rank held Novartis as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.